Abstract
Aluminum chloride (AlCl3) is commonly used in daily life; meanwhile, it is the potential etiology of various neurodegenerative as well as hepatorenal diseases. Therefore, the present study was carried out to investigate the correlation between AlCl3-induced biochemical alterations and the toxicity induced in various organs such as the brain, liver, and kidney. Male mice received AlCl3 in an oral dose of 50 mg kg−1 in addition to (50 mg) in drinking water for 2 weeks. Two weeks post-AlCl3 intoxication, the brain, liver, and kidney biochemical indices were assessed via molecular and western blot analysis. The results are as follows: AlCl3 intoxication induced a significant elevation in serum malondialdehyde in addition to a significant reduction in serum glutathione (GSH) and superoxide dismutase (SOD) levels. Brain β-secretase (tubulin-binding protein) and tau proteins which are responsible for the synthesis of β-amyloid protein that may interfere with neuronal communication in Alzheimer’s disease (AD) were also upregulated; regarding hepatic function, AlCl3 elevated serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities. Moreover, it upregulated hepatic mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) protein expressions as well as renal kidney-inducible molecule-1 (KIM-1) which indicated the deleterious effect of AlCl3 on these organs. These results were confirmed by histopathological investigations. So, we hypothesize that acute AlCl3 administration is responsible for oxidative cell damage that interferes with brain function inducing β-amyloid accumulation, Alzheimer’s disease, and neurodegenerative damage as well as hepatorenal injuries.
Similar content being viewed by others
References
Ochmanski W, Barabasz W (2000) Aluminum-occurrence and toxicity fororganisms. Przegl Lek 57:665–668
Gupta VB, Anitha S, Hegda ML et al (2005) Aluminum in Alzheimer’s disease: are we still at a crossroad? Cell Mol Life Sci 62:143–158
Mahieu S, del Carmen Contini M, Gonzalez M et al (2000) Aluminum toxicity. Hematological effects. Toxicol Lett 111:235–242
LaFerla FM, Oddo S (2005) Alzheimer’s disease: a beta, tau and synaptic dysfunction. Trends Mol Med 11:170–176
Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K (2012) A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature. 488(7409):96–99
Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, DeStrooper B, Saftig P, Birchmeier C, Haass C (2006) Control of peripheral nerve myelination by the beta-secretase BACE1. Science. 314(5799):664–666
Seternes OM, Johansen B, Hegge B, Johannessen M, Keyse SM, Moens U (2002) Both binding and activation of p38 mitogen-activated protein kinase (MAPK) play essential roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress. Mol Cell Biol 22:6931–6945
Seternes OM, Mikalsen T, Johansen B, Michaelsen E, Armstrong CG, Morrice NA, Turgeon B, Meloche S, Moens U, Keyse SM (2004) Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway. EMBO J 23:4780–4791
Liu C-M, Ma J-Q, Yun-Zhi S (2012) Puerarin protects rat kidney from lead-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol 258:330–342
Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV (2002) Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62(1):237–244
Al-Hashem F (2009) Camel’s milk protects against aluminum chloride-induced normocytic normocromic anemia, lipid peroxidation and oxidative stress in erythrocytes of white albino rats. Am J Biochem Biotechnol 5(3):126–136
Fiejka M, Fiejka E, Długaszek M (1996) Effect of aluminium hydroxide administration on normal mice: tissue distribution and ultrastructual localization of aluminium in liver. Pharmacol Toxicol 78:123–128
Reitman S, Frankle S (1957) A colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Path 28(1):56–63
Moron MS, Depierre J, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochem.Biophys.Acta. 582:67–78
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C (T)) method. Methods. 25:402–408
Nishida M, Tanabe S, Maruyama Y, Mangmool S, Urayama K, Nagamatsu Y, Takagahara S, Turner JH, Kozasa T, Kobayashi H, Sato Y, Kawanishi T, Inoue R, Nagao T, Kurose H (2005) Gά and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. J Biol Chem 280:18434–18441
Bancroft JD, Stevens A (1996) Theory and practice of histological techniques, vol 163, 4th edn. Churchill Livingstone, London
Erazi H, Sansar W, Ahboucha S, Gamrani H (2010) Aluminum affects glial system and behavior of rats. C R Biol 333:23–27
Ittel TH, Buddington B, Miller NL, Alfrey AC (1987) Enhanced gastrointestinal absorption of aluminium in uremic rats. Kidney Int 32:821–826
Długaszek M, Fiejka MA, Graczyk A, Aleksandrowicz JC, Slowikowska M (2000) Effects of various aluminium compounds given orally to mice on Al tissue distribution and tissue concentrations of essential elements. Pharmacol Toxicol 86(3):135–139
Xu F, Liu Y, Zhao H, Yu K, Song M, Zhu Y, Li Y (2017) Aluminum chloride caused liver dysfunction and mitochondrial energy metabolism disorder in rat. J Inorg Biochem 174:55–62
Kaehny W, Hegg A, Alfrey A (1997) Gastrointestinal absorption of aluminum from aluminum containing antacids. New Engl J Med 296:1389–1390
Dennis JM, Witting PK (2017) Protective role for antioxidants in acute kidney disease. Nutrients 9(7):E718
Campbell A (2002) The potential role of aluminum in Alzheimer’s disease. Nephrol Dial Transplant 17:17–20
Andreadis A (2006) Misregulation of tau alternative splicing in neurodegeneration and dementia. Prog Mol Subcell Biol 44:89–107
Giunta S, Andriolo V, Castorina A (2014) Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride. Int J Biochem Cell Biol 54:122–136
Jovanović MD, Jelenković A, Stevanović ID et al (2014) Protective effects of glucose-6-phosphate dehydrogenase on neurotoxicity of aluminium applied into the CA1 sector of rat hippocampus. Indian J Med Res 139(6):864–872
El-Sebae AH, Abdel-Ghanv ME, Shalloway D et al (2008) Aluminum interaction with human brain tau protein phosphorylation by various kinases. J Environ Sci Health 28:763–777
Acknowledgments
Acknowledgments is directed to Prof. Dr. Olfat Ali Hammam, professor of pathology, Theodor Bilharz Research Institute, for histopathological aid, and to Prof. Dr. Laila Rashed, professor of Biochemistry Faculty of Medicine, Cairo University, for technical aid.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hassan, S.A., Kadry, M.O. Neurodegenerative and Hepatorenal Disorders Induced Via Aluminum Chloride in Murine System: Impact of β-Secretase, MAPK, and KIM. Biol Trace Elem Res 199, 227–236 (2021). https://doi.org/10.1007/s12011-020-02132-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-020-02132-9